The Egyptian Drug Authority has launched a series of warnings against counterfeit and substandard medical products, including medicines, contact lenses, and cosmetics. The authority has intensified its inspection and regulatory campaigns to combat the circulation of fake or unknown origin products. This move aims to protect citizens and ensure the safety and quality of products on the market. The authority has issued several warnings regarding "commercial fraud" and "recall and confiscation" decisions.
The authority has identified several counterfeit products, including EPOETIN 4000 IU vial, Exforge 10/160 mg tablets, and Flebogamma 5% DIF Solution for infusion. These products were found to have fake or unknown origin packaging, and the companies that produce the original products have denied manufacturing them. The authority has urged citizens and pharmacists to be cautious when purchasing medicines and medical supplies.
The authority has also warned against several types of contact lenses, including Jamila Cool Lenses 30 days, SENORITA CONTACT LENSES, Fresh LADY, SHEGLAM LENS, and CELIA Contact Lenses. These products are unknown origin and not registered in the authority's central database for medical supplies. The authority has instructed relevant authorities to take action to confiscate these products.
In addition, the authority has decided to recall and confiscate three batches of different products due to non-compliance with specifications. These products include vilaphoria 40 mg film coated tablet, purified water USP 44, and R&B Cleopatra keratin solution. The authority has taken these measures to ensure the safety and quality of products on the market.
The authority has emphasized that the warnings and recalls only apply to specific batches and do not affect all products with the same name. Citizens and pharmacists are advised to be cautious when purchasing products and to verify their authenticity. The authority has also provided a hotline (15301) and an official website for citizens to report any suspicions or inquiries.
The Egyptian Drug Authority has taken these measures to protect citizens from counterfeit and substandard products. The authority is committed to ensuring the safety and quality of products on the market. The warnings and recalls are part of the authority's efforts to intensify its inspection and regulatory campaigns.
The authority's efforts aim to maintain the trust of citizens in the medical products available on the market. The authority will continue to monitor and regulate the market to ensure compliance with specifications and standards. Citizens are advised to report any suspicious products or activities to the authority.
Key points
- The Egyptian Drug Authority warns against counterfeit and substandard medical products, including medicines, contact lenses, and cosmetics.
- The authority has identified several counterfeit products and taken measures to recall and confiscate them.
- Citizens are advised to be cautious when purchasing products and to verify their authenticity.
